DK1513878T3 - Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 - Google Patents
Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100Info
- Publication number
- DK1513878T3 DK1513878T3 DK03748180T DK03748180T DK1513878T3 DK 1513878 T3 DK1513878 T3 DK 1513878T3 DK 03748180 T DK03748180 T DK 03748180T DK 03748180 T DK03748180 T DK 03748180T DK 1513878 T3 DK1513878 T3 DK 1513878T3
- Authority
- DK
- Denmark
- Prior art keywords
- apo
- apolipoprotein
- methods
- concerns
- compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 101800001976 Apolipoprotein B-48 Proteins 0.000 abstract 2
- 102400000352 Apolipoprotein B-48 Human genes 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 108010008150 Apolipoprotein B-100 Proteins 0.000 abstract 1
- 102000006991 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000923 atherogenic effect Effects 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Light Receiving Elements (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207542A FR2841249A1 (fr) | 2002-06-19 | 2002-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
| PCT/FR2003/001888 WO2004000884A2 (fr) | 2002-06-19 | 2003-06-19 | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1513878T3 true DK1513878T3 (da) | 2007-07-16 |
Family
ID=29719858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03748180T DK1513878T3 (da) | 2002-06-19 | 2003-06-19 | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050152900A1 (da) |
| EP (1) | EP1513878B1 (da) |
| JP (1) | JP2006515561A (da) |
| AT (1) | ATE356832T1 (da) |
| AU (1) | AU2003267493A1 (da) |
| CA (1) | CA2489057A1 (da) |
| DE (1) | DE60312513T2 (da) |
| DK (1) | DK1513878T3 (da) |
| ES (1) | ES2283803T3 (da) |
| FR (1) | FR2841249A1 (da) |
| WO (1) | WO2004000884A2 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070207505A1 (en) * | 2004-03-29 | 2007-09-06 | Shibayagi Co., Ltd. | Method for Mesurement of Apoliporotein B-48 and its Use |
| WO2007058588A1 (en) * | 2005-11-18 | 2007-05-24 | T.A.C Thrombosis And Coagulation Aktiebolag | Monoclonal antibodies against apolipoprotein m |
| EP2005172A4 (en) * | 2006-03-23 | 2009-05-06 | Emelita De Guzman Breyer | APOLIPOPROTEIN-FINGERPRINT PROCESS |
| EP3756767B1 (en) | 2007-10-02 | 2024-05-01 | Labrador Diagnostics LLC | Modular point-of-care devices and uses thereof |
| JP5832723B2 (ja) * | 2009-03-06 | 2015-12-16 | 協和メデックス株式会社 | 可溶性インターロイキン−２受容体定量用標準品 |
| EP2408812B1 (en) * | 2009-03-17 | 2015-12-16 | CardioVax, LLC | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions |
| AU2010319323B2 (en) | 2009-11-14 | 2015-01-15 | Cardiovax, Llc | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis |
| US8506964B2 (en) | 2010-02-05 | 2013-08-13 | Cardiovax, Llc | Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| CA2817543A1 (en) | 2010-11-12 | 2012-06-07 | Cedars-Sinai Medical Center | Immunomodulatory methods and systems for treatment and/or prevention of hypertension |
| CN103501806A (zh) | 2010-11-12 | 2014-01-08 | 赛达斯西奈医疗中心 | 用于治疗和/或预防动脉瘤的免疫调节方法和系统 |
| CA3097861A1 (en) | 2011-01-21 | 2012-07-26 | Labrador Diagnostics Llc | Systems and methods for sample use maximization |
| US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
| US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
| US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
| US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
| US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
| US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
| US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
| US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
| US11008628B1 (en) | 2013-02-18 | 2021-05-18 | Labrador Diagnostics Llc | Systems and methods for analyte testing and laboratory oversight |
| US10401373B1 (en) | 2013-02-18 | 2019-09-03 | Theranos Ip Company, Llc | Systems and methods for analyte testing and laboratory oversight |
| US10422806B1 (en) | 2013-07-25 | 2019-09-24 | Theranos Ip Company, Llc | Methods for improving assays of biological samples |
| US11360107B1 (en) | 2014-02-25 | 2022-06-14 | Labrador Diagnostics Llc | Systems and methods for sample handling |
| CN106053793A (zh) * | 2016-06-20 | 2016-10-26 | 诺莱生物医学研究院（北京）有限公司 | 一种快速检测乳糜血的免疫层析试纸卡及其制备方法 |
| WO2025111449A1 (en) * | 2023-11-21 | 2025-05-30 | Sun Diagnostics, Inc. | Method and reagent to clear turbidity due to elevated triglycerides in a biological specimen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60193926A (ja) * | 1984-03-15 | 1985-10-02 | Tokyo Daigaku | 単クローン性抗ヒトアポリポ蛋白質ｂ１００抗体 |
| JPS617299A (ja) * | 1984-06-20 | 1986-01-13 | Dai Ichi Pure Chem Co Ltd | ヒトアポリポ蛋白ｂ４８に高い特異性を有する単クローン性抗体 |
| US6635623B1 (en) * | 1997-06-13 | 2003-10-21 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
-
2002
- 2002-06-19 FR FR0207542A patent/FR2841249A1/fr active Pending
-
2003
- 2003-06-19 AU AU2003267493A patent/AU2003267493A1/en not_active Abandoned
- 2003-06-19 AT AT03748180T patent/ATE356832T1/de not_active IP Right Cessation
- 2003-06-19 DK DK03748180T patent/DK1513878T3/da active
- 2003-06-19 EP EP03748180A patent/EP1513878B1/fr not_active Expired - Lifetime
- 2003-06-19 WO PCT/FR2003/001888 patent/WO2004000884A2/fr not_active Ceased
- 2003-06-19 US US10/513,916 patent/US20050152900A1/en not_active Abandoned
- 2003-06-19 JP JP2004514955A patent/JP2006515561A/ja active Pending
- 2003-06-19 CA CA002489057A patent/CA2489057A1/fr not_active Abandoned
- 2003-06-19 ES ES03748180T patent/ES2283803T3/es not_active Expired - Lifetime
- 2003-06-19 DE DE60312513T patent/DE60312513T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1513878B1 (fr) | 2007-03-14 |
| WO2004000884A2 (fr) | 2003-12-31 |
| CA2489057A1 (fr) | 2003-12-31 |
| WO2004000884A3 (fr) | 2004-04-08 |
| ATE356832T1 (de) | 2007-04-15 |
| AU2003267493A1 (en) | 2004-01-06 |
| DE60312513T2 (de) | 2007-12-06 |
| FR2841249A1 (fr) | 2003-12-26 |
| JP2006515561A (ja) | 2006-06-01 |
| ES2283803T3 (es) | 2007-11-01 |
| EP1513878A2 (fr) | 2005-03-16 |
| US20050152900A1 (en) | 2005-07-14 |
| DE60312513D1 (de) | 2007-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1513878T3 (da) | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 | |
| WO2003106964A3 (en) | High throughput methods and devices for assaying analytes in a fluid sample | |
| EP1312919A3 (en) | Sample volume metering apparatus | |
| BR9710836A (pt) | Ensaio de analitos usando marcas em partìculas | |
| AU2849300A (en) | Methods and assay kits for detecting mononuclear cell phenotype | |
| WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
| DE69941688D1 (de) | Immunoassays unter verwendung von sers (surface enhanced raman scattering) | |
| EP1359417A3 (en) | Devices and methods for analyte concentration determination | |
| SG111139A1 (en) | Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays | |
| MXPA02010106A (es) | Determinacion de suficiencia de volumen de muestra en dispositivos biosensores. | |
| AU2002350779A1 (en) | Analyzer and analysing method and a fluid cartridge | |
| TW200606420A (en) | Biosensors having improved sample application and uses thereof | |
| KR970701789A (ko) | 콜레스테롤의 정량방법(method for quantitatively determining cholesterol) | |
| WO2001038873A3 (en) | Devices and methods for detecting analytes using electrosensor having capture reagent | |
| ATE522812T1 (de) | Verfahren und zusammensetzung zum bestimmen von homocystein | |
| DE60204418D1 (de) | "High-Density-Lipoprotein"-Testvorrichtung und Verfahren | |
| WO2004042403A3 (en) | Methods, device and instrument for detection of analytes | |
| ATE382861T1 (de) | Universeller biosensor und verfahren zur verwendung | |
| WO2004079343A3 (en) | Sample preparation for colorimetric and fluorescent assays as implemented on optical analysis discs | |
| WO2002077645A3 (en) | Method for the measurement of soluble analytes | |
| DE60220288D1 (de) | Bestimmung der Genauigkeit eines Probevolumens in Biosensoren | |
| CA2586654A1 (en) | Use of asc as a marker for colorectal cancer | |
| WO2004016802A3 (en) | Methods and apparatus for preparing and assaying biological samples to determine protein concentration | |
| WO2002014869A3 (en) | Assay method and device for detecting the presence and concentration of analytes | |
| DK1423708T3 (da) | Sammensætninger og fremgangsmåder til bestemmelser af AA4RP |